Autolus Competitors and Similar CompaniesClear all

Autolus's competitors and similar companies include Cellink.
Autolus
Autolus
Autolus Therapeutics is a private biopharmaceutical company, focused on the development and commercialization of engineered T-cell immunotherapy products.
Cellink
Cellink
CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.
Founding Date
Founding Date
2014
Founding Date
2016
Type
Type
Public
Type
Subsidiary
Tags
Locations
Locations
London, GB HQ
London, GB
Locations
Göteborg, SE HQ
Dardilly, FR
Kyoto, JP
Göteborg, SE
Brighton, GB
Blacksburg, US
Boston, US
Employees
Employees
647
Employees
851% decrease

Financial

Revenue (est.)
Revenue (est.)
$75.4m (FY, 2025)
Revenue (est.)
kr74.2m (FY, 2021)
Cost of goods
Cost of goods
$86.6m (FY, 2025)
Cost of goods
kr40.2m (FY, 2021)
Gross profit
Gross profit
($10.7m) (FY, 2025)
Gross profit
kr34.1m (FY, 2021)
Net income
Net income
($287.5m) (FY, 2025)
Net income
(kr27.4m) (FY, 2021)

Funding

Total funding raised
Total funding raised
$ 281.7m
Total funding raised
$ 4.1m
For sources of this data, please see the company profile

View Company Profiles

Cellink
HQ
Göteborg, SE

CELLINK is a company that develops bioprinting technologies that allow researchers to 3D print human organs and tissue models of pharmaceutical and cosmetic products.

View company